ZMC(600216)2024-10-24 07:33Financial Performance - Revenue for Q3 2024 reached CNY 2,707,337,059.93, an increase of 39.66% compared to the same period last year[2] - Net profit attributable to shareholders was CNY 534,319,800.14, a significant increase of 1,737.57% year-on-year[2] - Net profit excluding non-recurring gains and losses for the period was CNY 529,302,742.23, up 2,564.26% from the previous year[2] - Year-to-date revenue reached CNY 7,112,804,346.30, reflecting a growth of 21.04% compared to the same period last year[2] - Year-to-date net profit attributable to shareholders was CNY 849,651,818.01, an increase of 181.96% year-on-year[2] - Basic earnings per share for Q3 2024 were CNY 0.56, up 1,766.67% from the same period last year[3] - Total operating revenue for the first three quarters of 2024 reached CNY 7,112,804,346.30, a significant increase of 21.0% compared to CNY 5,876,518,447.27 in the same period of 2023[12] - Net profit for the first three quarters of 2024 was CNY 758,558,082.68, compared to CNY 180,865,708.32 in 2023, indicating a substantial increase of 319.5%[14] - The total comprehensive income attributable to shareholders of the parent company is ¥848,266,025.98, compared to ¥306,821,011.56 in the same period last year, reflecting a strong overall performance[15] Assets and Liabilities - Total assets at the end of the reporting period were CNY 13,429,512,113.31, a 5.09% increase from the end of the previous year[3] - The total assets of the company as of the end of Q3 2024 amounted to CNY 13,429,512,113.31, up from CNY 12,779,539,756.21 at the end of Q3 2023, representing a growth of 5.1%[12] - The total liabilities increased slightly to CNY 2,820,110,790.11 in Q3 2024 from CNY 2,793,145,986.32 in Q3 2023, showing a growth of 1.0%[12] - Shareholders' equity attributable to shareholders was CNY 10,341,301,291.01, reflecting a 7.38% increase year-on-year[3] - The total equity attributable to shareholders reached CNY 10,341,301,291.01 in Q3 2024, up from CNY 9,630,715,541.49 in Q3 2023, indicating an increase of 7.4%[12] Cash Flow - The company reported a net cash flow from operating activities of CNY 692,060,136.95 for the year-to-date, an increase of 68.51% compared to the previous year[3] - Cash flow from operating activities for the first three quarters of 2024 is ¥692,060,136.95, compared to ¥410,703,114.95 in the same period of 2023, reflecting a strong operational performance[17] - The total amount of cash and cash equivalents as of September 30, 2024, was RMB 1,635,716,620.56, up from RMB 1,460,026,640.19, reflecting an increase of approximately 12%[10] - The company's cash and cash equivalents increased to CNY 1,000,000,000.00 in Q3 2024, compared to CNY 800,000,000.00 in Q3 2023, reflecting a growth of 25.0%[12] - The cash and cash equivalents at the end of the period amount to ¥1,635,529,620.56, up from ¥1,349,552,417.87 at the end of the previous year, showing improved liquidity[18] - The company experienced a net increase in cash and cash equivalents of ¥175,689,980.37, compared to a decrease of -¥88,356,849.04 in the same period last year, indicating better cash management[18] Shareholding Structure - The company reported a total of 208,192,361 shares held by New Changxin Investment Development Co., Ltd., making it the largest shareholder[8] - The second-largest shareholder, Guotou High-tech Investment Co., Ltd., holds 151,127,573 shares, representing a significant stake in the company[8] - The company has no significant changes in the shareholding structure among the top 10 shareholders compared to the previous period[9] Operational Insights - The increase in revenue and profit was primarily driven by higher sales and prices of key products, including Vitamin E and Vitamin A[5] - Operating costs for the first three quarters of 2024 were CNY 6,103,341,032.99, up from CNY 5,607,285,954.16 in 2023, reflecting a growth of 8.8%[12] - Research and development expenses for the first three quarters of 2024 were CNY 546,930,073.32, a decrease of 9.9% from CNY 607,134,841.28 in the same period of 2023[14] - The company has not reported any significant new product developments or technological advancements during this quarter[9] - There are no notable mergers or acquisitions reported in the current quarter, and the company has not disclosed any new strategic initiatives[9] Inventory and Receivables - As of September 30, 2024, total current assets reached RMB 6,146,702,104.36, an increase from RMB 5,601,409,763.89 at the end of December 2023, reflecting a growth of approximately 9.7%[10] - Accounts receivable increased to RMB 1,690,337,783.45 from RMB 1,252,230,303.53, representing a significant rise of about 35%[10] - Inventory decreased to RMB 1,945,483,588.92 from RMB 2,010,704,310.63, indicating a reduction of approximately 3.2%[10] Long-term Borrowings - The company’s long-term borrowings increased to CNY 372,307,500.00 in Q3 2024 from CNY 230,222,800.00 in Q3 2023, reflecting a growth of 61.6%[12]